March 1, 2024 · Form 4 insider transaction
McCourt Marion sold 358 shares of Regeneron Pharmaceuticals, Inc. at $967.50 per share, a transaction worth $346.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023.